CLOVER HEALTH INVESTMENTS, CORP. /DE Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $312.16 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2021-05-17
- CLOVER HEALTH INVESTMENTS, CORP. /DE cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2021-03-31 was $312.16M, a 595.29% increase year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2020-03-31 was $44.90M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2020 was $28.00M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $312.16M 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $28.00M 10-K · filed 2021-03-31 | ||||
| 2020-09-30 | $126.75K 10-Q · filed 2020-11-16 | ||||
| 2020-06-30 | $750.54K 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | $44.90M 10-Q · filed 2021-05-17 | $63.37K 10-Q · filed 2020-06-04 |